Clinical Trial Update: Mesenchymal Stem Cells in Knee Cartilage Injuries [Phase 2]

View source ↗

Summary

Phase 2 study evaluating mesenchymal stem cells for knee cartilage injuries has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Articular Cartilage Defect of the Knee
• Osteoarthritis of the Knee

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: University of Jordan | Conditions: Articular Cartilage Disorder of Knee, Osteoarthritis, Knee | Phase 2 | Status: COMPLETED